RNF168 facilitates oestrogen receptor ɑ transcription and drives breast cancer proliferation

Oestrogen receptor ɑ (ERɑ) is overexpressed in two‐thirds of all breast cancers and involves in development and breast cancer progression. Although ERɑ‐positive breast cancer could be effective treated by endocrine therapy, the endocrine resistance is still an urgent clinical problem. Thus, further...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhenhua, Zhang, Jinghang, Xu, Juntao, Yang, Huijie, Li, Xin, Hou, Yingxiang, Zhao, Yan, Xue, Min, Wang, Beibei, Yu, Na, Yu, Sifan, Niu, Gang, Wu, Gaosong, Li, Xiumin, Wang, Hui, Zhu, Jian, Zhuang, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111850/
https://www.ncbi.nlm.nih.gov/pubmed/29974997
http://dx.doi.org/10.1111/jcmm.13694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111850/
https://www.ncbi.nlm.nih.gov/pubmed/29974997
http://dx.doi.org/10.1111/jcmm.13694

Ejemplares similares